Clinical Factors Related to Cardiac Conduction Disturbance in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy Undergoing Tafamidis Treatment.

Vyndaqel (tafamidis meglumine) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42724167

Daiki Okamoto; Fuminari Tatsugami; Kotaro Hamamoto; Toshiro Kitagawa; Yoshiharu Sada; Yukiko Nakano

Sep 12, 2026